CURATIVE BIOSCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0015 USD | -.--% |
|
-.--% | -.--% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2016 | - | Sales 2017 | - | Capitalization | 17.66L 15Cr |
|---|---|---|---|---|---|
| Net income 2016 | -10L -8.34Cr | Net income 2017 | - 0 | EV / Sales 2016 | - |
| Net Debt 2016 | 50.03T 41.71L | Net Debt 2017 | 62.83T 52.38L | EV / Sales 2017 | - |
| P/E ratio 2016 |
-3.53
x | P/E ratio 2017 |
-33.2
x | Employees | 6 |
| Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 70.57% |
More Fundamentals
* Assessed data
Current year
0.00
0.00
1 year
0.000.00
3 years
0.000.17
5 years
0.000.60
10 years
0.005.48
Curative Biosciences, Inc., formerly Amaize Beverage Corporation, is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD (hemp derived Cannabidiol). The Companyâs product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 4L | |
| +37.57% | 435.2Cr | |
| +137.81% | 220.91Cr | |
| +153.97% | 7.86Cr |
- Stock Market
- Equities
- CBDX Stock
